Publications by authors named "Alexandr Chernov"

Claim this Profile
P
Prognostic model for pediatric brain tumors based on tumor microenvironment-specific gene signatures.
Yuxin Liu, Longgang Sang, Alexandr N Chernov, Guodong Liu, Tao Jiang

Discov Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy sensitivity of primary glioblastoma cells and immunohistochemical markers to predict of survival of patients with of glioblastoma.
Alexandr Chernov, Aleksei Chutko, Diana Alaverdian, Vadim Kashuro, Elvira Galimova

Clin Transl Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomimetic CuSe nanoplatforms for efficient glioblastoma treatment: overcoming the blood-brain barrier and boosting Immunogenetic cell death.
Sijia Lin, Haiyan Xing, Yu Zeng, Elvira Galimova, Alexandr Chernov

J Nanobiotechnology· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Benefits of Whole-Exome Sequencing in the Differential Diagnosis of Hypophosphatasia.
Oleg S Glotov, Natalya A Zhuchenko, Maria S Balashova, Aleksandra N Raspopova, Victoria V Tsai, Alexandr N Chernov

Int J Mol Sci· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting CD45 by gene-edited CAR T cells for leukemia eradication and hematopoietic stem cell transplantation preconditioning.
Valeria M Stepanova, Dmitry V Volkov, Daria S Osipova, Wenjian Wang, Yingqin Hou, Alexandr S Chernov

Mol Ther Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of molecular markers and synergistic anticancer effects of chemotherapy with antimicrobial peptides on glioblastoma cells.
Alexandr N Chernov, Alexandr V Kim, Sofia S Skliar, Evgeniy V Fedorov, Anna N Tsapieva

Cancer Chemother Pharmacol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nerve Growth Factor, Antimicrobial Peptides and Chemotherapy: Glioblastoma Combination Therapy to Improve Their Efficacy.
Alexandr Chernov, Igor Kudryavtsev, Aleksei Komlev, Diana Alaverdian, Anna Tsapieva

Biomedicines· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polymorphisms in corticotrophin-releasing hormone-proopiomalanocortin (CRH-POMC) system genes: Neuroimmune contributions to psoriasis disease.
Elvira Galimova, Ranno Rätsep, Tanel Traks, Alexandr Chernov, Darya Gaysina

J Eur Acad Dermatol Venereol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secretory Phospholipase A2 and Interleukin-6 Levels as Predictive Markers of the Severity and Outcome of Patients with COVID-19 Infections.
Stanislav Urazov, Alexandr Chernov, Oleg Popov, Natalya Klenkova, Natalya Sushentseva

Int J Mol Sci· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switchable targeting of solid tumors by BsCAR T cells.
Alexey V Stepanov, Roman S Kalinin, Victoria O Shipunova, Ding Zhang, Jia Xie, Alexandr S Chernov

Proc Natl Acad Sci U S A· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenetic Study of the Impact of Single Nucleotide Polymorphisms on the Response to Cyclosporine in Psoriasis Patients.
Alexandr Chernov, Daria Kilina, Tatiana Smirnova, Elvira Galimova

Pharmaceutics· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and Genetic Characteristics of Pediatric Patients with Hypophosphatasia in the Russian Population.
Oleg S Glotov, Kirill V Savostyanov, Tatyana S Nagornova, Alexandr N Chernov, Mikhail A Fedyakov

Int J Mol Sci· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anticancer Effect of Cathelicidin LL-37, Protegrin PG-1, Nerve Growth Factor NGF, and Temozolomide: Impact on the Mitochondrial Metabolism, Clonogenic Potential, and Migration of Human U251 Glioma Cells.
Alexandr N Chernov, Tatiana A Filatenkova, Ruslan I Glushakov, Alexandra S Buntovskaya, Diana A Alaverdian

Molecules· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Phenomenon of Multidrug Resistance in Glioblastomas.
Alexandr N Chernov, Diana A Alaverdian, Elvira S Galimova, Alessandra Renieri, Elisa Frullanti

Hematol Oncol Stem Cell Ther· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Vitro Evaluation of the Cytotoxic Effect of Strains, Protegrin PG-1, Cathelicidin LL-37, Nerve Growth Factor and Chemotherapy on the C6 Glioma Cell Line.
Alexandr N Chernov, Anna Tsapieva, Diana A Alaverdian, Tatiana A Filatenkova, Elvira S Galimova

Molecules· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Related expression of TRKA and P75 receptors and the changing copy number of MYC-oncogenes determine the sensitivity of brain tumor cells to the treatment of the nerve growth factor in combination with cisplatin and temozolomide.
Alexandr N Chernov, Diana A Alaverdian, Oleg S Glotov, Michael V Talabaev, Stanislav P Urazov

Drug Metab Pers Ther· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Related expression of TRKA and P75 receptors and the changing copy number of -oncogenes determine the sensitivity of brain tumor cells to the treatment of the nerve growth factor in combination with cisplatin and temozolomide.
Alexandr N Chernov, Diana A Alaverdian, Oleg S Glotov, Michael V Talabaev, Stanislav P Urazov

Drug Metab Pers Ther· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methionine γ-lyase in enzyme prodrug therapy: An improvement of pharmacokinetic parameters of the enzyme.
Elena A Morozova, Vitalia V Kulikova, Natalya V Anufrieva, Alexey N Minakov, Alexandr S Chernov

Int J Biol Macromol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis